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Abbreviations: ERM, ezrin-radixin-moesin, Fz, Frizzled, LEF, lymphoid enhancer factor, LRP6, low-density lipoprotein
receptor-related proteins, TCF, T-cell factor
CD44 was recently identified as a positive feedback regulator of Wnt/b-catenin signaling. This regulation occurs at
the level of low-density lipoprotein receptor-related protein 6 phosphorylation and membrane targeting. These
findings broaden our understanding of the Wnt pathway activation process and open new perspectives for anti-CD44
therapies in diseases associated with Wnt induction, including colorectal cancer.
Wnt/b-catenin signaling is activated
upon binding of Wnt ligands to both Friz-
zled (Fz) receptors and low-density lipo-
protein receptor-related protein 5/6
(LRP5/6) co-receptors (reviewed in 1).
This activation results in the inhibition of
b-catenin degradation and its cytosolic
accumulation. Subsequent b-catenin
translocation to the nucleus leads to T-cell
factor/lymphoid enhancer factor (TCF/
LEF)-driven transcription. Among the
Wnt target genes are regulators of cell pro-
liferation, growth, differentiation, and
migration. Hence, Wnt/b-catenin signal-
ing plays key roles in development
(reviewed in 1). This pathway also regu-
lates homeostasis of bones, hematopoiesis,
and renewal of tissues such as the intestine
or the skin, and therefore remains essential
throughout life. Consequently, misregula-
tion of Wnt/b-catenin signaling leads to
developmental defects, malformations,
degenerative and metabolic diseases, and
cancer (reviewed in 1). A tight regulation
of Wnt signaling involves feedback con-
trol mechanisms in which the expression
of several Wnt-signaling components is
regulated by Wnt/b-catenin signaling
itself (reviewed in 1).
The cell adhesion molecule CD44 was
identified as a canonical Wnt target in the
intestine, where it is highly expressed in
intestinal stem and proliferative progeni-
tor cells. Loss of CD44 in ApcMin/C mice
significantly reduced the tumor number in
the small intestine, thus indicating an
involvement of CD44 in Wnt-induced
tumorigenesis.2 Furthermore, increased
CD44 expression correlates with late
stages and poor prognosis of colorectal
cancer.3 However, considering CD44
solely as a Wnt target gene might only be
part of the story. In fact, our recent paper4
shows that CD44 also acts as a positive
Wnt feedback regulator. In several cell
lines, silencing of all CD44 isoforms sup-
pressed Wnt-induced activation and
nuclear translocation of b-catenin, as well
as TCF/LEF-driven transcription. Con-
versely, overexpression of CD44 isoforms
enhanced Wnt signaling regardless of the
isoform, suggesting the involvement of a
function common to all CD44 isoforms
in the regulation of this pathway. A CD44
isoform with deletion of the cytoplasmic
domain had no effect on Wnt pathway
activation, indicating that the CD44 cyto-
plasmic domain is essential for the
involvement of CD44 in Wnt signaling.
Ezrin, a member of the Ezrin-Radixin-
Moesin (ERM) protein family, links
CD44 to the cytoskeleton (reviewed in
5). Interference with the binding of
ezrin to CD44 resulted in loss of CD44
regulatory function. The association of
CD44 to ERM proteins and to the
cytoskeleton seems to be essential for
Wnt signaling.
Wnt pathway activation at the level of
Wnt3a, LRP6, Dishevelled, or b-catenin
revealed regulation by CD44 at the level
of membrane receptors. Co-immunopre-
cipitation experiments identified a Wnt-
inducible LRP6–CD44 complex. Down-
regulation of CD44 demonstrated a role
of CD44 both in LRP6 phosphorylation,
an event that is Wnt-dependent, and in
LRP6 membrane targeting, a step that is
Wnt independent. These findings suggest
a dual mechanism of action of CD44 in
Wnt signaling (Fig. 1). Both of these
functions depend on the cytoplasmic
domain of CD44 and its binding to F-
actin via Ezrin. Finally, experiments in
Xenopus laevis demonstrated an in vivo
requirement of CD44 for Wnt/b-catenin
signaling in CNS development, as indi-
cated by reduced expression of the Wnt-
target genes tcf-4 and engrailed-2 in CD44
morphants.
The activity of the Wnt cascade is regu-
lated at each step from the cell surface to
the nucleus (reviewed in 1). What could
be the additional contribution of CD44?
One important characteristic of CD44 is
its ability to bind to the cytoskeleton
through ERM proteins. This network
formed by the CD44–ERM–actin com-
plex might provide a platform necessary
for the tight association between LRP6
and kinases such as glycogen synthase kin-
ase 3b and casein kinase 1g. Additionally,
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trafficking of the LRP6-containing vesicles
from the Golgi to the membrane might
take place within the F-actin rich cortex.
These F-actin tracks might be tethered to
the plasma membrane through the CD44-
ERM complex. Although these hypotheses
are highly speculative one should note that
CD44 can be found on coat protein com-
plex 1 (COP1) vesicles involved in vesicle
trafficking.6 Additionally, CD44 was
shown to co-localize with soluble NSF
attachment protein receptors (SNAREs)
that play important roles in the fusion of
vesicles with the plasma membrane.7
CD44 is not the only Wnt-target gene
providing positive feedback regulation in
Wnt/b-catenin signaling. Other positive
regulators like LEF1 or Fz-receptors have
been shown to be upregulated upon acti-
vation of canonical Wnt signaling.
Positive feedback loops between CD44
and Wnt signaling might be required dur-
ing development or for homeostasis of
various organs, including the limbs or the
skin. The intestinal epithelium, a highly
dynamic tissue that is renewed every 4 to
5 days, is also a strong candidate for such
regulation. Indeed, renewal of the intesti-
nal epithelium requires permanently active
Wnt signals in the intestinal stem and pro-
liferative progenitor cells. Inactivation of
canonical Wnt signaling in the intestine
causes a complete loss of proliferation of
intestinal progenitor cells at the bottom of
the intestinal crypts. Severe effects on
stem cell maintenance and proliferation
were also observed.8 Interestingly, an iso-
form-specific function of CD44 in this
intestinal stem and proliferative progeni-
tor compartment was recently suggested.9
In conclusion, our findings reveal a
completely new aspect of CD44, namely
as a regulator of Wnt signaling at the level
of LRP6, and add another regulatory
function to the already described roles of
CD44 in signaling. In colorectal cancer,
CD44 might act as a Wnt target gene in
concert with Met.10 Additionally, CD44
might influence the activity of the Wnt
pathway in a positive feedback loop. Dis-
tinguishing the role of CD44 as a target
gene or as a Wnt-regulator might be diffi-
cult. However, anti-CD44 therapies
should be seriously considered, especially
in colorectal cancers.
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Figure 1. Dual impact of CD44 on Wnt/b-catenin signaling. (A) In the absence of Wnt ligands, CD44
bound to F-actin via ERMs regulates membrane targeting and cell surface expression of LRP6. (B) In
the presence of Wnts, CD44 forms a complex with LRP6 and participates in LRP6 activation. This
step is also highly dependent on the association of CD44 with the actin cytoskeleton via ERMs.
Abbreviations: APC, adenomatous polyposis coli; CK1, casein kinase 1; ER, endoplasmic reticulum;
ERM, ezrin-radixin-moesin; GSK3, glycogen synthase kinase; LRP6, low-density lipoprotein receptor-
related proteins; TCF, T-cell factor.
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